Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. annual/quarterly total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Vivos Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 26.7M, a 264.28% increase year-over-year.
- Vivos Therapeutics, Inc. total liabilities for 2025 were 26.7M, a 264.28% increase from 2024.
- Vivos Therapeutics, Inc. total liabilities for 2024 were 7.3M, a 28.97% decrease from 2023.
- Vivos Therapeutics, Inc. total liabilities for 2023 were 10.3M, a 15.70% increase from 2022.
- Vivos Therapeutics, Inc. total liabilities for 2022 were 8.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vivos Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $7 |
| 2023 | $10 |
| 2022 | $9 |
| 2021 | $8 |
| 2020 | $8 |
| 2019 | $9 |
| Vivos Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $27 |
| 2024-12-31 | $7 |
| 2023-12-31 | $10 |
| 2022-12-31 | $9 |
| 2021-12-31 | $8 |
| 2020-12-31 | $8 |
| 2019-12-31 | $9 |
Vivos Therapeutics, Inc. Total Liabilities — FAQ
Vivos Therapeutics, Inc. (VVOS) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's total liabilities history?
The chart and table above show Vivos Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.